Kisoka William J, Simonsen Paul E, Malecela Mwelecele N, Tersbøl Britt P, Mushi Declare L, Meyrowitsch Dan W
National Institute for Medical Research, Dar es Salaam, Tanzania; Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark.
PLoS One. 2014 Oct 8;9(10):e109316. doi: 10.1371/journal.pone.0109316. eCollection 2014.
In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania.
A questionnaire based cross sectional household survey was carried out in two rural and two urban districts in Lindi and Morogoro regions shortly after the 2011 MDA. 3279 adults (≥15 years) were interviewed about personal characteristics, socio-economic status, MDA drug uptake among themselves and their children, reasons for taking/not taking drugs, and participation in previous MDA activities for LF control.
The overall drug uptake rate was 55.1% (range of 44.5-75.6% between districts). There was no overall major difference between children (54.8%) and adults (55.2%) or between females (54.9%) and males (55.8%), but the role of these and other predictors varied to some extent between study sites. Major overall predictors of drug uptake among the interviewed adults were increasing age and history of previous drug uptake. Being absent from home during drug distribution was the main reason for not taking the drugs (50.2%) followed by clinical contraindications to treatment (10.8%), missing household visits of drug distributors (10.6%), and households not being informed about the distribution (9.0%).
Drug uptake relied more on easily modifiable provider-related factors than on individual perceptions and practices in the target population. Limited investments in appropriate timing, dissemination of accurate timing information to recipients and motivation of drug distributors to visit all households (repeatedly when residents are absent) are likely to have considerable potential for increasing drug uptake, in support of successful LF transmission elimination.
在撒哈拉以南非洲的大多数国家,淋巴丝虫病(LF)的控制基于每年一次的伊维菌素和阿苯达唑联合群体药物给药(MDA)。然而,对于在合理时间内实现传播阻断目标的项目而言,治疗覆盖率往往不尽人意。本研究旨在确定坦桑尼亚国家淋巴丝虫病消除计划在实施MDA期间个人药物服用的预测因素和障碍。
在2011年MDA之后不久,在林迪和莫罗戈罗地区的两个农村和两个城市地区开展了一项基于问卷调查的横断面家庭调查。对3279名成年人(≥15岁)进行了访谈,内容包括个人特征、社会经济地位、他们自己及其子女的MDA药物服用情况、服药/未服药的原因以及参与此前LF控制MDA活动的情况。
总体药物服用率为55.1%(各地区之间为44.5 - 75.6%)。儿童(54.8%)和成年人(55.2%)之间以及女性(54.9%)和男性(55.8%)之间总体上没有重大差异,但这些因素及其他预测因素的作用在不同研究地点之间存在一定程度的差异。受访成年人中药物服用的主要总体预测因素是年龄增长和既往药物服用史。药物分发时不在家是未服药的主要原因(50.2%),其次是治疗的临床禁忌症(10.8%)、错过药物分发人员的家访(10.6%)以及家庭未被告知分发情况(9.0%)。
药物服用更多地依赖于易于改变的与提供者相关的因素,而非目标人群的个人认知和行为。在合适的时间进行有限投资、向接受者传播准确的时间信息以及激励药物分发人员走访所有家庭(当居民不在时反复走访),对于提高药物服用率可能具有相当大潜力,以支持成功消除淋巴丝虫病传播。